[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].国际内分泌代谢杂志, 2021, 41(5): 482-548. DOI: 10.3760/cma.j.cn121383-20210825-08063. [2] LI Y Z, TENG D, SHI X G, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997. DOI: 10.1136/bmj.m997. [3] ASSOCIATION A D. Standards of medical care in diabetes: 2010[J]. Diabetes Care, 2010, 33(Suppl 1): S11-S61. DOI: 10.2337/dc10-S011. [4] PYLYPCHUK R, WELLS S, KERR A, et al. Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study[J]. Lancet, 2021, 397(10291): 2264-2274. DOI: 10.1016/S0140-6736(21)00572-9. [5] ARNLÖV J, EVANS J C, MEIGS J B, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study[J]. Circulation, 2005, 112(7): 969-975. DOI: 10.1161/CIRCULATIONAHA.105.538132. [6] TAO J, SANG D S, ZHANG X X, et al. An elevated urinary albumin-to-creatinine ratio increases the risk of incident cardia-cerebrovascular disease in individuals with type 2 diabetes[J]. Diabetol Metab Syndr, 2024, 16(1): 30. DOI: 10.1186/s13098-024-01256-5. [7] SCIRICA B M, MOSENZON O, BHATT D L, et al. Cardiovascular outcomes according to urinary albumin and kidney disease in patients with type 2 diabetes at high cardiovascular risk: observations from the SAVOR-TIMI 53 trial[J]. JAMA Cardiol, 2018, 3(2): 155-163. DOI: 10.1001/jamacardio.2017.4228. [8] WU S L, HUANG Z R, YANG X C, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city[J]. Circ Cardiovasc Qual Outcomes, 2012, 5(4): 487-493. DOI: 10.1161/CIRCOUTCOMES.111.963694. [9] LEVEY A S, STEVENS L A, SCHMID C H, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612. DOI: 10.7326/0003-4819-150-9-200905050-00006. [10] NOWAK C, ÄRNLÖV J. Kidney disease biomarkers improve heart failure risk prediction in the general population[J]. Circ Heart Fail, 2020, 13(8): e006904. DOI: 10.1161/circheartfailure.120.006904. [11] ORLANDI P F, XIE D W, YANG W, et al. Slope of kidney function and its association with longitudinal mortality and cardiovascular disease among individuals with CKD[J]. J Am Soc Nephrol, 2020, 31(12): 2912-2923. DOI: 10.1681/ASN.2020040476. [12] LEES J S, WELSH C E, CELIS-MORALES C A, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease[J]. Nat Med, 2019, 25(11): 1753-1760. DOI: 10.1038/s41591-019-0627-8. [13] MATSUSHITA K, CORESH J, SANG Y Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data[J]. Lancet Diabetes Endocrinol, 2015, 3(7): 514-525. DOI: 10.1016/S2213-8587(15)00040-6. [14] VADUGANATHAN M, PAREEK M, KRISTENSEN A M D, et al. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy[J]. Eur J Heart Fail, 2021, 23(3): 384-392. DOI: 10.1002/ejhf.1971. [15] LI M, CHENG A C, SUN J K, et al. The role of urinary albumin-to-creatinine ratio as a biomarker to predict stroke: a meta-analysis and systemic review[J]. Brain Circ, 2021, 7(3): 139-146. DOI: 10.4103/bc.bc_64_20. [16] MIRABITO COLAFELLA K M, BOVÉE D M, DANSER A H J. The renin-angiotensin-aldosterone system and its therapeutic targets[J]. Exp Eye Res, 2019, 186: 107680. DOI: 10.1016/j.exer.2019.05.020. [17] HE J, SHLIPAK M, ANDERSON A, et al. Risk factors for heart failure in patients with chronic kidney disease: the CRIC(chronic renal insufficiency cohort)study[J]. J Am Heart Assoc, 2017, 6(5): e005336. DOI: 10.1161/JAHA.116.005336. [18] ZHANG H, SHI S, ZHAO X J, et al. Association between the lipid profile and renal dysfunction in the heart failure patients[J]. Kidney Blood Press Res, 2019, 44(1): 52-61. DOI: 10.1159/000498834. [19] MCCLELLAN W M, FLANDERS W D, LANGSTON R D, et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study[J]. J Am Soc Nephrol, 2002, 13(7): 1928-1936. DOI: 10.1097/01.asn.0000018409.45834.fa. [20] HEIN A M, SCIALLA J J, SUN J L, et al. Estimated glomerular filtration rate variability in patients with heart failure and chronic kidney disease[J]. J Card Fail, 2021, 27(11): 1175-1184. DOI: 10.1016/j.cardfail.2021.04.016. [21] 那娜,江洪. 尿白蛋白与尿肌酐比值在2型糖尿病治疗中的研究进展[J].中华临床医师杂志(电子版), 2015, 9(21): 3969-3972. DOI: 10.3877/cma.j.issn.1674-0785.2015.21.028. [22] TOYODA K. The cerebro-renal interaction in stroke neurology[J]. Neurology, 2012, 78(24): 1898-1899. DOI: 10.1212/WNL.0b013e318259e29f. [23] BARZILAY J I, PETERSON D, CUSHMAN M, et al. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study[J]. Am J Kidney Dis, 2004, 44(1): 25-34. DOI: 10.1053/j.ajkd.2004.03.022. [24] DE ZEEUW D, PARVING H H, HENNING R H. Microalbuminuria as an early marker for cardiovascular disease[J]. J Am Soc Nephrol, 2006, 17(8): 2100-2105. DOI: 10.1681/asn.2006050517. |